Worth reading
52Recurring
Scored from 5 of 6 sectionsDirection
Mixed performance
Direction inferred from the company’s description.Scale
1395
¥ millionWording
Conditional
How definitive the wording is.Results for this period
Interim period (second quarter)1 January 2026–30 June 2026ConsolidatedJapanese GAAPNet Sales180,369¥ millionYear on year +9.7%Progress 46.2%
Operating profit4,654¥ millionYear on year +42.8%Progress 38.8%
Ordinary income7,220¥ millionYear on year +31.1%Progress 51.6%
Net income attributable to owners of the parent4,973¥ millionYear on year +32.8%Progress 55.3%
The width of the band at each stage is based on revenue. The narrower it becomes toward the bottom, the smaller the proportion of revenue that remains as profit. The dotted outline is the full-year forecast and the band inside it is the result for this period. The progress rate is the result divided by the forecast.
Net income per share¥79.32
Financial position at period-end
Total assets386,623¥ million
of which net assets 270,854 ¥ millionEquity ratio 69.9%vs. prior year-end -0.6pt
塗りつぶした部分が自己資本比率です。総資産のうち、返済のいらない自前の資金がどれだけかを表します。The thin vertical line indicates the level at the end of the previous fiscal year.
Segment revenue
Health and Food Business21,18711.7%+2.1%
Dairy Business32,17817.8%+4.9%
Nutritional Confectionery Business29,92416.6%+0.2%
Food Ingredients Business6,2733.5%-1.6%
Domestic Other Businesses36,74120.4%+2.1%
Overseas Business54,06330.0%+32.3%
Segment profit
Health and Food Business-1,442
Dairy Business-4,168
Nutritional Confectionery Business968-51.2%
Food Ingredients Business1,222+23.6%
Domestic Other Businesses143-43.6%
Overseas Business7,577+66.1%
Regional sales
China1,43993.1%+39.1%
ASEAN613.9%-4.7%
United States463.0%+1.1%
Outlook and shareholder returns
Full-year earnings forecast
Net Sales¥390,000 million (YoY +7.9%)
Operating profit¥12,000 million (YoY +37.4%)
Ordinary income¥14,000 million (YoY +20.2%)
Net income¥9,000 million (YoY +78.7%)
Revision to Earnings ForecastNet Sales ¥380,000 million → ¥390,000 million（+2.6%） / Operating profit ¥14,000 million → ¥12,000 million（-14.3%） / Ordinary income Not disclosed → ¥14,000 million / Net income Not disclosed → ¥9,000 million
Annual Dividend Forecast¥95 → ¥95（0.0%）
Factors Behind Changes in Business Performance
The factors affecting the increase or decrease in operating profit were stated as follows: ¥7,064 million from changes in revenue; △¥4,415 million from fluctuations in raw material prices; ¥408 million from other changes in costs; ¥1,552 million from changes in the freight and storage cost ratio; △¥1,382 million from changes in sales promotion and advertising expenses; and △¥1,832 million from changes in general and administrative expenses.
Disclosure regarding the going concern assumption
There are no notes regarding the going concern assumption.
Change in accounting policy
基準改正に伴う変更 Noそれ以外の変更 No見積りの変更 No修正再表示 No
Changes in the scope of consolidationNew 0 / Excluded 0 / Company name None
Impairment lossNot applicable. There is no information on impairment losses on fixed assets by reporting segment.
Availability of Supplementary Financial Results MaterialsYes
Availability of Financial Results BriefingWhether applicable Yes / Subject person Analysts and institutional investors
Issued Shares at Period-End68,468,569
Treasury Shares at Period-End7,159,857
| Item | Details |
|---|---|
| Fiscal Period Classification | Interim period (second quarter) |
| Accounting standards | Japanese GAAP |
| Consolidated / non-consolidated | Consolidated |
| Period Covered | 1 January 2026–30 June 2026 |
| Net Sales | ¥180,369 million (YoY +9.7%) |
| Operating profit | ¥4,654 million (YoY +42.8%) |
| Ordinary income | ¥7,220 million (YoY +31.1%) |
| Profit attributable to owners of the parent | ¥4,973 million (YoY +32.8%) |
| Net income per share | ¥79.32 |
| Equity ratio | End of the current fiscal period 69.9 / End of previous period 70.5 |
| Total assets | ¥386,623 million |
| Net assets | ¥270,854 million |
| Full-year earnings forecast | Net Sales ¥390,000 million (YoY +7.9%) / Operating profit ¥12,000 million (YoY +37.4%) / Ordinary income ¥14,000 million (YoY +20.2%) / Net income ¥9,000 million (YoY +78.7%) |
| Revision to Earnings Forecast | Net Sales ¥380,000 million → ¥390,000 million（+2.6%） / Operating profit ¥14,000 million → ¥12,000 million（-14.3%） / Ordinary income Not disclosed → ¥14,000 million / Net income Not disclosed → ¥9,000 million |
| Annual Dividend Forecast | ¥95 → ¥95（0.0%） |
| Segment revenue | Health and Food Business ¥21,187 million (YoY +2.1%) / Dairy Business ¥32,178 million (YoY +4.9%) / Nutritional Confectionery Business ¥29,924 million (YoY +0.2%) / Food Ingredients Business ¥6,273 million (YoY -1.6%) / Domestic Other Businesses ¥36,741 million (YoY +2.1%) / Overseas Business ¥54,063 million (YoY +32.3%) |
| Segment profit | Health and Food Business ¥-1,442 million / Dairy Business ¥-4,168 million / Nutritional Confectionery Business ¥968 million (YoY -51.2%) / Food Ingredients Business ¥1,222 million (YoY +23.6%) / Domestic Other Businesses ¥143 million (YoY -43.6%) / Overseas Business ¥7,577 million (YoY +66.1%) |
| Regional sales | China 1,439 Millions of yuan (YoY +39.1%) / ASEAN 61 USD million (YoY -4.7%) / United States 46 USD million (YoY +1.1%) |
| Impairment loss | Not applicable. There is no information on impairment losses on fixed assets by reporting segment. |
| Disclosure regarding the going concern assumption | There are no notes regarding the going concern assumption. |
| Change in accounting policy | Changes due to revisions to standards No / Other changes No / Change in accounting estimate No / Restatement No |
| Changes in the scope of consolidation | New 0 / Excluded 0 / Company name None |
| Availability of Supplementary Financial Results Materials | Yes |
| Availability of Financial Results Briefing | Whether applicable Yes / Subject person Analysts and institutional investors |
| Issued Shares at Period-End | 68,468,569 |
| Treasury Shares at Period-End | 7,159,857 |
| Factors Behind Changes in Business Performance | The factors affecting the increase or decrease in operating profit were stated as follows: ¥7,064 million from changes in revenue; △¥4,415 million from fluctuations in raw material prices; ¥408 million from other changes in costs; ¥1,552 million from changes in the freight and storage cost ratio; △¥1,382 million from changes in sales promotion and advertising expenses; and △¥1,832 million from changes in general and administrative expenses. |
Items this document does not state (11)
Operating MarginCash flows from operating activitiesCash flows from investing activitiesCash flows from financing activitiesCash and cash equivalents at end of periodPayout ratioShareholder Return PolicyOrders received and order backlogDepreciation and amortizationBreakdown of extraordinary income (loss)Material subsequent events
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.Revenue exceeded the year-earlier period in the dairy business, domestic other businesses and overseas business, among others. Operating profit benefited from higher gross profit, including increased revenue in China within the overseas business, but selling expenses, salaries and allowances also increased. The full-year forecast revisions reflect the progress of results during the interim period and the recent operating environment.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.